- Home
- BRTX vs BIOR Comparison
BRTX vs BIOR Comparison
Compare BRTX & BIOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- BIOR
- Stock Information
- Founded
- BRTX 1997
- BIOR 2010
- Country
- BRTX United States
- BIOR United States
- Employees
- BRTX N/A
- BIOR N/A
- Industry
- BRTX Managed Health Care
- BIOR Biotechnology: Pharmaceutical Preparations
- Sector
- BRTX Health Care
- BIOR Health Care
- Exchange
- BRTX Nasdaq
- BIOR Nasdaq
- Market Cap
- BRTX 11.3M
- BIOR 12.6M
- IPO Year
- BRTX N/A
- BIOR 2020
- Fundamental
- Price
- BRTX $1.46
- BIOR $2.12
- Analyst Decision
- BRTX Strong Buy
- BIOR Strong Buy
- Analyst Count
- BRTX 1
- BIOR 1
- Target Price
- BRTX $18.00
- BIOR $150.00
- AVG Volume (30 Days)
- BRTX 34.6K
- BIOR 121.2K
- Earning Date
- BRTX 11-12-2024
- BIOR 11-14-2024
- Dividend Yield
- BRTX N/A
- BIOR N/A
- EPS Growth
- BRTX N/A
- BIOR N/A
- EPS
- BRTX N/A
- BIOR N/A
- Revenue
- BRTX $377,000.00
- BIOR $892,000.00
- Revenue This Year
- BRTX $598.90
- BIOR $32,550.00
- Revenue Next Year
- BRTX $162.81
- BIOR $95.48
- P/E Ratio
- BRTX N/A
- BIOR N/A
- Revenue Growth
- BRTX 189.55
- BIOR 4855.56
- 52 Week Low
- BRTX $1.03
- BIOR $2.03
- 52 Week High
- BRTX $3.67
- BIOR $19.90
- Technical
- Relative Strength Index (RSI)
- BRTX 39.02
- BIOR 25.71
- Support Level
- BRTX $1.44
- BIOR $2.44
- Resistance Level
- BRTX $1.78
- BIOR $3.10
- Average True Range (ATR)
- BRTX 0.16
- BIOR 0.36
- MACD
- BRTX -0.01
- BIOR -0.03
- Stochastic Oscillator
- BRTX 24.93
- BIOR 4.95
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About BIOR Biora Therapeutics Inc.
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.